# OnCo record nct07551362 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07551362/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07551362", "NCT07551362" ;
  schema:name "Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer"@en ;
  schema:alternateName "DUET-GEJ"@en ;
  schema:description "A phase 1/2 trial of Fludarabine and Cyclophosphamide in gastric & gastro-oesophageal junction cancer, run by Beijing Biotech, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07551362/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07551362> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2026-03-02" ;
  onco:cancers <https://onco.cc/cancers/gastric/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/fludarabine/>, <https://onco.cc/drugs/cyclophosphamide/> .